MENLO PARK, Calif.--(BUSINESS WIRE)--Bioabsorbable Therapeutics Inc. announced the close of a Series B round of US$9MM today. CEO Patrick Rivelli said, “We are delighted with the investment round, led by Finistere Ventures LLC and ITX International Equity Corp. This investment will help us begin human clinical trials and move closer to regulatory approval and commercialization.”
